Overexpression of transglutaminase 2 accelerates the erythroid differentiation of human chronic myelogenous leukemia K562 cell line through PI3K/Akt signaling pathway

MLA

Sung-Koo Kang, et al. “Overexpression of Transglutaminase 2 Accelerates the Erythroid Differentiation of Human Chronic Myelogenous Leukemia K562 Cell Line through PI3K/Akt Signaling Pathway.” FEBS Letters, vol. 577, Oct. 2004, pp. 361–66. EBSCOhost, https://doi.org/10.1016/j.febslet.2004.10.031.

APA

Sung-Koo Kang, Tae-Wook Chung, Cheorl-Ho Kim, & Ji Young Lee. (2004). Overexpression of transglutaminase 2 accelerates the erythroid differentiation of human chronic myelogenous leukemia K562 cell line through PI3K/Akt signaling pathway. FEBS Letters, 577, 361–366. https://doi.org/10.1016/j.febslet.2004.10.031

Chicago

Sung-Koo Kang, Tae-Wook Chung, Cheorl-Ho Kim, and Ji Young Lee. 2004. “Overexpression of Transglutaminase 2 Accelerates the Erythroid Differentiation of Human Chronic Myelogenous Leukemia K562 Cell Line through PI3K/Akt Signaling Pathway.” FEBS Letters 577 (October): 361–66. doi:10.1016/j.febslet.2004.10.031.